ophthalmologytimes5 天
Phase 3 LUGANO Trial explores EYP-1901’s potential to reduce treatment burden in wet AMD ...
In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s ...